Charles Schwab Investment Management Inc Biote Corp. Call Options Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BTMD
# of Institutions
56Shares Held
12.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$28.8 Million10.43% of portfolio
-
Bandera Partners LLC New York, NY2.01MShares$15.3 Million4.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$10.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY973KShares$7.44 Million0.0% of portfolio
-
Kanen Wealth Management LLC Coral Springs, FL838KShares$6.41 Million3.21% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $57.9M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...